Author

Volker Wiebking

Stanford MedicineORCID 0000-0002-9429-5254Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Volker Wiebking1 paper

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:CITE-seq· 1 Research Focus:drug response / drug discovery· 1 Approach:genetic perturbation / CRISPR· 1 Organism:mouse· 1

Frequent Co-Authors

Aditi ChandraiD· 1 shared Alexander J. DimitriiD· 1 shared Alexander T. DilsiD· 1 shared Amy E. BaxteriD· 1 shared Bruce L. LevineiD· 1 shared Caitlin R. HopkinsiD· 1 shared Christopher Holliday· 1 shared David L. PorteriD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Aditi ChandraORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

ImmunologyScience AdvancesPeer-reviewedNov 13, 2024

TET2 regulates early and late transitions in exhausted CD8+ T-cell differentiation and limits CAR T-cell function

Alexander J. Dimitri, Amy E. Baxter, Gregory M. Chen…·Joseph A. Fraietta

This study shows that targeting TET2 in CAR T-cells improves their anti-tumor responses by limiting terminal exhaustion and enhancing therapeutic potential.

42 citationstop 2%

𝕏 PostBluesky